Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B

E. Fikrig, H. Tao, M. Chen, Stephen W Barthold, R. A. Flavell

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The evolution of Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi outer surface proteins (Osps) A or B was assessed to investigate the role of immunity to OspA or B in infection and pathogenesis of Lyme disease. Antibodies to OspA or B protect immunocompetent C3H/HeJ or C.B.17 severe combined immunodeficient (scid) mice from challenge with B. burgdorferi. Moreover, arthritis in infected C3H mice resolves with the rise of high titers of B. burgdorferi specific antibodies, including OspA and B, whereas disease persists in scid mice-suggesting that the regression of arthritis may he due to the development of borreliacidal OspA or B antibodies. To evaluate the course of Lyme borreliosis in OspA or B tolerant mice we developed transgenic mice that expressed OspA or B under control of the major histocompatibility complex (MHC) class I promoter. Mice carrying OspA or B transgenes on a C3H/HeJ (C3H, disease-susceptible) or C57BL/6 (B6, disease-resistant) background, immunized with OspA or B, did not mount a humoral or cellular immune response to OspA or B, respectively, but responded normally to other B. burgdorferi antigens. The evolution of Lyme borreliosis, including infection and the development of arthritis and carditis, was similar in transgenic and nontransgenic littermates suggesting that an OspA or B immune response is not singularly involved in either the genesis or regression of Lyme disease in C3H or B6 mice.

Original languageEnglish (US)
Pages (from-to)1706-1714
Number of pages9
JournalJournal of Clinical Investigation
Volume96
Issue number4
StatePublished - 1995
Externally publishedYes

Fingerprint

Borrelia burgdorferi
Lyme Disease
Transgenic Mice
Arthritis
SCID Mice
Antibodies
Inbred C3H Mouse
Myocarditis
Humoral Immunity
Infection
Major Histocompatibility Complex
Transgenes
Cellular Immunity
Immunity
Antigens

Keywords

  • antibody
  • arthritis
  • Lyme disease
  • spirochete
  • tolerance

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B. / Fikrig, E.; Tao, H.; Chen, M.; Barthold, Stephen W; Flavell, R. A.

In: Journal of Clinical Investigation, Vol. 96, No. 4, 1995, p. 1706-1714.

Research output: Contribution to journalArticle

Fikrig, E. ; Tao, H. ; Chen, M. ; Barthold, Stephen W ; Flavell, R. A. / Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B. In: Journal of Clinical Investigation. 1995 ; Vol. 96, No. 4. pp. 1706-1714.
@article{ee1d330fe7284d4198247b400497a8e1,
title = "Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B",
abstract = "The evolution of Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi outer surface proteins (Osps) A or B was assessed to investigate the role of immunity to OspA or B in infection and pathogenesis of Lyme disease. Antibodies to OspA or B protect immunocompetent C3H/HeJ or C.B.17 severe combined immunodeficient (scid) mice from challenge with B. burgdorferi. Moreover, arthritis in infected C3H mice resolves with the rise of high titers of B. burgdorferi specific antibodies, including OspA and B, whereas disease persists in scid mice-suggesting that the regression of arthritis may he due to the development of borreliacidal OspA or B antibodies. To evaluate the course of Lyme borreliosis in OspA or B tolerant mice we developed transgenic mice that expressed OspA or B under control of the major histocompatibility complex (MHC) class I promoter. Mice carrying OspA or B transgenes on a C3H/HeJ (C3H, disease-susceptible) or C57BL/6 (B6, disease-resistant) background, immunized with OspA or B, did not mount a humoral or cellular immune response to OspA or B, respectively, but responded normally to other B. burgdorferi antigens. The evolution of Lyme borreliosis, including infection and the development of arthritis and carditis, was similar in transgenic and nontransgenic littermates suggesting that an OspA or B immune response is not singularly involved in either the genesis or regression of Lyme disease in C3H or B6 mice.",
keywords = "antibody, arthritis, Lyme disease, spirochete, tolerance",
author = "E. Fikrig and H. Tao and M. Chen and Barthold, {Stephen W} and Flavell, {R. A.}",
year = "1995",
language = "English (US)",
volume = "96",
pages = "1706--1714",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "4",

}

TY - JOUR

T1 - Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B

AU - Fikrig, E.

AU - Tao, H.

AU - Chen, M.

AU - Barthold, Stephen W

AU - Flavell, R. A.

PY - 1995

Y1 - 1995

N2 - The evolution of Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi outer surface proteins (Osps) A or B was assessed to investigate the role of immunity to OspA or B in infection and pathogenesis of Lyme disease. Antibodies to OspA or B protect immunocompetent C3H/HeJ or C.B.17 severe combined immunodeficient (scid) mice from challenge with B. burgdorferi. Moreover, arthritis in infected C3H mice resolves with the rise of high titers of B. burgdorferi specific antibodies, including OspA and B, whereas disease persists in scid mice-suggesting that the regression of arthritis may he due to the development of borreliacidal OspA or B antibodies. To evaluate the course of Lyme borreliosis in OspA or B tolerant mice we developed transgenic mice that expressed OspA or B under control of the major histocompatibility complex (MHC) class I promoter. Mice carrying OspA or B transgenes on a C3H/HeJ (C3H, disease-susceptible) or C57BL/6 (B6, disease-resistant) background, immunized with OspA or B, did not mount a humoral or cellular immune response to OspA or B, respectively, but responded normally to other B. burgdorferi antigens. The evolution of Lyme borreliosis, including infection and the development of arthritis and carditis, was similar in transgenic and nontransgenic littermates suggesting that an OspA or B immune response is not singularly involved in either the genesis or regression of Lyme disease in C3H or B6 mice.

AB - The evolution of Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi outer surface proteins (Osps) A or B was assessed to investigate the role of immunity to OspA or B in infection and pathogenesis of Lyme disease. Antibodies to OspA or B protect immunocompetent C3H/HeJ or C.B.17 severe combined immunodeficient (scid) mice from challenge with B. burgdorferi. Moreover, arthritis in infected C3H mice resolves with the rise of high titers of B. burgdorferi specific antibodies, including OspA and B, whereas disease persists in scid mice-suggesting that the regression of arthritis may he due to the development of borreliacidal OspA or B antibodies. To evaluate the course of Lyme borreliosis in OspA or B tolerant mice we developed transgenic mice that expressed OspA or B under control of the major histocompatibility complex (MHC) class I promoter. Mice carrying OspA or B transgenes on a C3H/HeJ (C3H, disease-susceptible) or C57BL/6 (B6, disease-resistant) background, immunized with OspA or B, did not mount a humoral or cellular immune response to OspA or B, respectively, but responded normally to other B. burgdorferi antigens. The evolution of Lyme borreliosis, including infection and the development of arthritis and carditis, was similar in transgenic and nontransgenic littermates suggesting that an OspA or B immune response is not singularly involved in either the genesis or regression of Lyme disease in C3H or B6 mice.

KW - antibody

KW - arthritis

KW - Lyme disease

KW - spirochete

KW - tolerance

UR - http://www.scopus.com/inward/record.url?scp=0028807371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028807371&partnerID=8YFLogxK

M3 - Article

C2 - 7560061

AN - SCOPUS:0028807371

VL - 96

SP - 1706

EP - 1714

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 4

ER -